Medicared For All Logo

Sima Porten in San Francisco, California

Home California San Francisco

Sima Porten has Urology as her primary medical specialty. Their primary office is: 400 Parnassus Ave in San Francisco, California.

They're a part of the: Ucsf Medical Group Business Services medical group which has around 1,073 members. You can call their office at 415-476-1000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Northwestern University Feinberg Medical School and graduated in 2006 (around 18 years of experience). They are listed as doing telehealth appointments.


Sima P Porten Office Phone and Directions

Sima Porten
Ucsf Medical Group Business Services
400 Parnassus Ave
San Francisco, California 94143
415-476-1000


Patient Ratings
Please rate your experience with Sima Porten below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 415-476-1000


Enter a starting address:


Healthcare Info for Sima Porten

Medical School: Northwestern University Feinberg Medical School
Graduation Year: 2006
The Primary Medical Specialty for Sima Porten is listed as: Urology
Approximate Years of Experience: 18
PAC (PECOS ID)#: 5496900391
NPI #: 1124157474
NPI Created On: 03/04/2007
NPI Last Updated Listed as: 08/04/2023
Primary Taxonomy Code: 208800000X
License Number:
XXXXXXXX
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Removal of bladder and lymph nodes on both sides of pelvis with transplantation of urinary ducts (ureters) to small or large bowel with creation of urinary opening
  2. Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope
  3. Destruction of (less than 0.5 centimeters) growths of the bladder and bladder canal (urethra) using an endoscope
  4. Destruction and/or removal of (0.5 to 2.0 centimeters) small growths of the bladder using an endoscope
  5. Destruction and/or removal of (2.0 to 5.0 centimeters) medium growths of the bladder and bladder canal (urethra) using an endoscope
  6. Removal of foreign body, stone, or stent from bladder canal (urethra) or bladder using an endoscope
  7. Insertion of stent in urinary duct (ureter) using an endoscope
  8. Removal of prostate gland
  9. Imaging of urinary tract
  10. New patient office or other outpatient visit, typically 30 minutes
  11. New patient office or other outpatient visit, typically 45 minutes
  12. New patient office or other outpatient visit, typically 60 minutes
  13. Established patient office or other outpatient visit, typically 15 minutes
  14. Established patient office or other outpatient, visit typically 25 minutes
  15. Established patient office or other outpatient, visit typically 40 minutes
  16. Physician telephone patient service, 11-20 minutes of medical discussion
  17. Physician telephone patient service, 21-30 minutes of medical discussion

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $8,800

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 826687683

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: UROTHELIAL CANCER

Name of Drug #1: JELMYTO

Open Associated Drug #1: 72493-103-03


Payments Total: $800

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 826687687

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: UROTHELIAL CANCER

Name of Drug #1: JELMYTO

Open Associated Drug #1: 72493-103-03


Payments Total: $1,080

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783579163

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $450

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 844308889

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Continence Care

Name of Drug #1: SpeediCath


Payments Total: $1,125

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 844308891

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Continence Care

Name of Drug #1: SpeediCath


Payments Total: $675

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 844308895

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Continence Care

Name of Drug #1: SpeediCath


Payments Total: $563

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 844308897

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Continence Care

Name of Drug #1: SpeediCath


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 806662849

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: VISUALIZATION

Name of Drug #1: L10


Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832635245

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: INLYTA

Open Associated Drug #1: 0069-0145-01


Payments Total: $124

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832653101

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: INLYTA

Open Associated Drug #1: 0069-0145-01


Urology Professionals in San Francisco

929 Clay St
San-francisco, CA
Golden Gate Urology Inc

45 Castro St
San-francisco, CA
Golden Gate Urology Inc

2100 Webster St
San-francisco, CA
Golden Gate Urology Inc

2200 Ofarrell St
San-francisco, CA
Permanente Medical Group Inc

2238 Geary Blvd
San-francisco, CA
Permanente Medical Group Inc

815 Hyde St
San-francisco, CA
Golden Gate Urology Inc

Providers in Ucsf Medical Group Business Services

1.Daniel

400 Parnassus Ave
San Francisco Ca 94143-2202
Ucsf Medical Group Business Services
Internal Medicine

2.Shoko Abe

400 Parnassus Ave
San Francisco Ca 94143-2202
Ucsf Medical Group Business Services
General Surgery

3.Theodore Abraham

400 Parnassus Ave
San Francisco Ca 94143-2202
Ucsf Medical Group Business Services
Cardiovascular Disease (cardiology)

4.Maria Abraham

400 Parnassus Ave
San Francisco Ca 94143-2202
Ucsf Medical Group Business Services
Cardiovascular Disease (cardiology)

5.Donald Abrams Md

400 Parnassus Ave
San Francisco Ca 94143-2202
Ucsf Medical Group Business Services
Medical Oncology

6.Deborah Adey

400 Parnassus Ave
San Francisco Ca 94143-2202
Ucsf Medical Group Business Services
Nephrology

View all 1,073 members of Ucsf Medical Group Business Services medical group